
Redentor M. Pasia
Examiner (ID: 16815, Phone: (571)272-9745 , Office: P/2479 )
| Most Active Art Unit | 2413 |
| Art Unit(s) | 2616, 2413, 2474, 2479, 2416 |
| Total Applications | 771 |
| Issued Applications | 563 |
| Pending Applications | 74 |
| Abandoned Applications | 158 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8465095
[patent_doc_number] => 20120270264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'DNA CONSTRUCT, AND PROCESS FOR PRODUCTION OF RECOMBINANT CHO CELL USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/498006
[patent_app_country] => US
[patent_app_date] => 2010-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13699
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/498006 | DNA CONSTRUCT, AND PROCESS FOR PRODUCTION OF RECOMBINANT CHO CELL USING SAME | Sep 20, 2010 | Abandoned |
Array
(
[id] => 6353792
[patent_doc_number] => 20100331523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Heterologous Protein Production Using The Twin Arginine Translocation Pathway'
[patent_app_type] => utility
[patent_app_number] => 12/874785
[patent_app_country] => US
[patent_app_date] => 2010-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16462
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331523.pdf
[firstpage_image] =>[orig_patent_app_number] => 12874785
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/874785 | Heterologous Protein Production Using The Twin Arginine Translocation Pathway | Sep 1, 2010 | Abandoned |
Array
(
[id] => 8265798
[patent_doc_number] => 20120165220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Uses of CD116 Expression Level'
[patent_app_type] => utility
[patent_app_number] => 13/393585
[patent_app_country] => US
[patent_app_date] => 2010-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8234
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393585
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393585 | Uses of CD116 Expression Level | Aug 30, 2010 | Abandoned |
Array
(
[id] => 11298118
[patent_doc_number] => 09506114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Identifying genetic variation in affected tissues'
[patent_app_type] => utility
[patent_app_number] => 13/392776
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13261
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392776
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/392776 | Identifying genetic variation in affected tissues | Aug 25, 2010 | Issued |
Array
(
[id] => 6070045
[patent_doc_number] => 20110044895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'METHODS AND COMPOSITIONS FOR REDUCING STEMNESS IN ONCOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/852973
[patent_app_country] => US
[patent_app_date] => 2010-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23159
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044895.pdf
[firstpage_image] =>[orig_patent_app_number] => 12852973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852973 | METHODS AND COMPOSITIONS FOR REDUCING STEMNESS IN ONCOGENESIS | Aug 8, 2010 | Abandoned |
Array
(
[id] => 11256998
[patent_doc_number] => 09481893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-01
[patent_title] => 'DNA capable of inducing osteoblast-specific expression'
[patent_app_type] => utility
[patent_app_number] => 13/389204
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 11808
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389204
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/389204 | DNA capable of inducing osteoblast-specific expression | Aug 5, 2010 | Issued |
Array
(
[id] => 10182695
[patent_doc_number] => 09212367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-15
[patent_title] => 'Methods for improving recombinant protein expression'
[patent_app_type] => utility
[patent_app_number] => 13/390297
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 7779
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390297
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/390297 | Methods for improving recombinant protein expression | Aug 5, 2010 | Issued |
Array
(
[id] => 8290318
[patent_doc_number] => 20120178647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'ENGINEERING OF ZINC FINGER ARRAYS BY CONTEXT-DEPENDENT ASSEMBLY'
[patent_app_type] => utility
[patent_app_number] => 13/386995
[patent_app_country] => US
[patent_app_date] => 2010-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22039
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386995
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/386995 | ENGINEERING OF ZINC FINGER ARRAYS BY CONTEXT-DEPENDENT ASSEMBLY | Aug 2, 2010 | Abandoned |
Array
(
[id] => 8265793
[patent_doc_number] => 20120165216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'METHOD FOR IDENTIFYING SENESCENT MESENCHYMAL STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/387694
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10165
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387694
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/387694 | METHOD FOR IDENTIFYING SENESCENT MESENCHYMAL STEM CELLS | Jul 29, 2010 | Abandoned |
Array
(
[id] => 8313544
[patent_doc_number] => 20120190573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'BIOMARKER OF LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/378654
[patent_app_country] => US
[patent_app_date] => 2010-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15410
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378654
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/378654 | BIOMARKER OF LUNG CANCER | Jul 26, 2010 | Abandoned |
Array
(
[id] => 6622999
[patent_doc_number] => 20100311107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Ultra-High Throughput Screening of Natural Products'
[patent_app_type] => utility
[patent_app_number] => 12/844046
[patent_app_country] => US
[patent_app_date] => 2010-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23048
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311107.pdf
[firstpage_image] =>[orig_patent_app_number] => 12844046
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/844046 | Ultra-High Throughput Screening of Natural Products | Jul 26, 2010 | Abandoned |
Array
(
[id] => 8199237
[patent_doc_number] => 20120122726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'MARKERS FOR ENDOMETRIAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/386536
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 67109
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 51
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122726.pdf
[firstpage_image] =>[orig_patent_app_number] => 13386536
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/386536 | Markers for endometrial cancer | Jul 22, 2010 | Issued |
Array
(
[id] => 10857251
[patent_doc_number] => 08883446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Human long pentraxin 3 expression system and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/387784
[patent_app_country] => US
[patent_app_date] => 2010-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5338
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387784
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/387784 | Human long pentraxin 3 expression system and uses thereof | Jul 19, 2010 | Issued |
Array
(
[id] => 10553915
[patent_doc_number] => 09278108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'HMGB1 binding nucleic acid molecule and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 13/383826
[patent_app_country] => US
[patent_app_date] => 2010-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 22173
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383826
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383826 | HMGB1 binding nucleic acid molecule and applications thereof | Jul 15, 2010 | Issued |
Array
(
[id] => 6198318
[patent_doc_number] => 20110030076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Methods and compositions for targeted cleavage and recombination'
[patent_app_type] => utility
[patent_app_number] => 12/804234
[patent_app_country] => US
[patent_app_date] => 2010-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 46123
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20110030076.pdf
[firstpage_image] =>[orig_patent_app_number] => 12804234
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/804234 | Methods and compositions for targeted cleavage and recombination | Jul 15, 2010 | Issued |
Array
(
[id] => 5992963
[patent_doc_number] => 20110014616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Rapid screening of biologically active nucleases and isolation of nuclease-modified cells'
[patent_app_type] => utility
[patent_app_number] => 12/803552
[patent_app_country] => US
[patent_app_date] => 2010-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14819
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12803552
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/803552 | Rapid screening of biologically active nucleases and isolation of nuclease-modified cells | Jun 28, 2010 | Abandoned |
Array
(
[id] => 8252348
[patent_doc_number] => 20120156672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'NOVEL STRINGENT SELECTABLE MARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/378006
[patent_app_country] => US
[patent_app_date] => 2010-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22287
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156672.pdf
[firstpage_image] =>[orig_patent_app_number] => 13378006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/378006 | Stringent selectable markers | Jun 14, 2010 | Issued |
Array
(
[id] => 11888275
[patent_doc_number] => 09758827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'miRNA fingerprint in the diagnosis of lung cancer'
[patent_app_type] => utility
[patent_app_number] => 13/376281
[patent_app_country] => US
[patent_app_date] => 2010-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 104
[patent_figures_cnt] => 25
[patent_no_of_words] => 14069
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/376281 | miRNA fingerprint in the diagnosis of lung cancer | Jun 6, 2010 | Issued |
Array
(
[id] => 6292739
[patent_doc_number] => 20100239608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS'
[patent_app_type] => utility
[patent_app_number] => 12/787755
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10680
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12787755
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/787755 | PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS | May 25, 2010 | Abandoned |
Array
(
[id] => 6121475
[patent_doc_number] => 20110077287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS'
[patent_app_type] => utility
[patent_app_number] => 12/787566
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10674
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077287.pdf
[firstpage_image] =>[orig_patent_app_number] => 12787566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/787566 | PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS | May 25, 2010 | Abandoned |